Elements like affected person traits and disease-related options affect surgical restoration in addition to therapy success following remedy with Keytruda (pembrolizumab) and Padcev (enfortumab vedotin-ejfv), in response to Dr. Alireza Ghoreifi. The professional then went on to say that these findings spotlight the impression of sufferers components on outcomes for these with urothelial most cancers handled with immunotherapy.
Notably, on the 2025 AUA Annual Assembly, investigators expanded on this matter by sharing knowledge on perioperative outcomes of consolidative surgical procedure following immunotherapy with Keytruda plus Padcev for sufferers with superior urothelial most cancers.
In an effort to greatest perceive this matter, Ghoreifi sat down with CURE for an interview stay from the 2025 AUA Assembly. Within the interview, he mentioned the important thing components affecting perioperative restoration and total therapy success for sufferers present process consolidative surgical procedure following immunotherapy with therapy of Keytruda and Padcev.
Ghoreifi works with the Home Workers and is part of Duke Urologic Oncology Fellowship, Duke Urology, at Duke College of Medication, positioned in Durham, North Caroline.
Transcript:
That is a very good query. There are two most important [categories of] components that may have an effect on surgical outcomes. One is affected person components. For instance, excessive BMI. We all know that sufferers who’ve excessive BMI [tend to have] worse surgical outcomes in sure procedures. Equally, comorbidities — corresponding to diabetes, hypertension, and smoking — are key components that impression surgical outcomes. Controlling these modifiable components can considerably optimize surgical outcomes in these sufferers.
The opposite class is disease-related options. The disease-related options are options that we attempt to modify via therapy, utilizing novel immunotherapy brokers to kill the most cancers. The goal of all these medical trials, surgical procedure, and associated research is to attain the optimum oncological outcomes for these sufferers. [This is] as a result of these are the sufferers that, with out therapy, the prognosis for these people may be very poor.
Transcript has been edited for readability and conciseness.
For extra information on most cancers updates, analysis and schooling, don’t neglect to subscribe to CURE®’s newsletters right here.
